The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: a prospective study

Article Abstract:

Ultrasonography appears to be a reliable means of assessing whether a spontaneous abortion is complete. Following a spontaneous abortion, also known as miscarriage, placental tissue may be left in the uterus. Distinguishing between a complete and incomplete miscarriage can be complicated if the cervix is closed and bleeding is not heavy. Some gynecologists recommend routine curettage, which is the surgical scraping of the uterus, in cases of suspected incomplete miscarriage while others advocate intervention only if necessary. Ultrasonography was used to detect the presence of placental tissue or uterine thickening in 62 women who suffered spontaneous abortions. Forty-eight of 49 patients with negative ultrasound results recovered without intervention. One developed cramps and bleeding and underwent curettage. Of 13 patients with positive ultrasound results who underwent curettage, nine actually had placental tissue left in the uterus.

Miscarriage

---

The impact of routine obstetric ultrasonographic screening in a low-risk population

Article Abstract:

Routine ultrasonographic examinations of pregnant women may be useful in detecting fetal abnormalities if the detection rate matches the rate of abnormalities found after birth. Researchers reviewed the records of 860 fetuses in 854 pregnancies for the rate of fetal abnormalities detected by ultrasound examinations at 18 to 20 weeks of pregnancy. Major abnormalities were found in 1.16% of fetuses and minor abnormalities were found in 4.19%. These defects were verified after birth, with only one false positive diagnosis of a minor defect. Quality ultrasonography and experienced ultrasound readers should be used.

Care and treatment, Methods, Pregnant women, Prenatal diagnosis

---

Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders

Article Abstract:

A system that includes reminders and follow-up phone calls does not appear to improve compliance with depot medroxyprogesterone acetate. This drug is an injectable contraceptive but it must be given within 14 weeks of a previous injection. Of 250 women attending a clinic to receive depot medroxyprogesterone acetate, all received a card for their next appointment and half also received a letter 2 weeks before the appointment plus a phone call if they did not show up. The rate of missed appointments was similar in both groups as was the discontinuation rate.

Usage, Patient compliance, Medroxyprogesterone

Similar abstracts:

• Abstracts: Thoughts after birth. Care management in the community: a case study. Caught unawares
• Abstracts: Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: prevention of implantation
• Abstracts: Effects of nutritional counseling on lipoprotein levels in a pediatric lipid clinic. Assessment of girls' genital findings and the likelihood of sexual abuse
• Abstracts: Compliance with childhood cholesterol screening among members of a prepaid health plan. Screening for familial hypercholesterolemia in childhood

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.